CLXClorox

$86.39-24% 1Y

$86.39

$80.4152 weeks$125.58

Is the price fair?

Fair

Neither cheap nor expensive: nothing decisive, though cheap against its own history.

1 good, 2 without data

What the price assumes~+9% a yearderived · Jun 30, 2026

Priced for ~9% a year FCF growth. Moderate growth expectations are priced in.

Vs its own P/E rangecheaper than 85% of its own historyderived

Cheap vs its own history: P/E 17.9 vs a 20.9 median over 41 quarters (−14% vs median).

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)middle of the market

FCF yieldmiddle of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

Clorox trades at 17.9× earnings against 24.3× for the median Household & Personal Products name, cheaper than its own group.

17.9

Trailing P/E · Household & Personal Products median 24.3 · cheaper than the typical name in its group

Price / sales: 1.55
Price / sales · today's price, trailing year to Jun 30, 2026
Free cash flow yield: 3.9%
Free cash flow yield · Household & Personal Products median 5.1%
Growth the price implies: +9.0%
Growth the price implies · The price pays for +9.0% free cash flow growth a year for a decade; the business has delivered −24% a year over the last three.

Details›

What the market has paid for these earnings: 41 quarters of its own multiple × $4.82 of trailing earnings per share
Method	Per share
Its own P/E history, lower quartile	$90.69
Its own P/E history, median	$100.55
Its own P/E history, upper quartile	$169.88
52-week range	$80.41 – $125.58
Today	$86.39

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.